A Long-Term Survivor’s Hope: End the HIV Epidemic

The COVID-19-related death toll in the United States recently surpassed 100,000. Estimates for how many more people will die because of COVID-19 vary wildly. Some are describing this situation as unprecedented.

It is not. And I know because I am a long-term survivor of HIV.

I have been living with HIV for nearly four decades and have attended more than my fair share of funerals. Too many times, I have sat in pews next to the grieving friends and family of someone we loved who was now in a casket or urn. The reality of what the HIV virus can do has shaped most of my adult life.

Today, June 5, is HIV Long-term Survivors Day, a day set aside to recognize the accomplishment of surviving and the needs of those of us who are thriving and aging with HIV. There are many unique things that we who are long-term survivors need to continue surviving, but there is one that we want for everyone: to end the HIV epidemic in the United States.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search